ProTek Capital Inc (PRPM) Stock Makes a Bullish Move: But Why?
Those who are currently looking into the stocks which may have recorded strong gains this morning could do well to take a closer look at the ProTek Capital Inc (OTCMKTS:PRPM) stock. It has emerged as one of the notable gainers today and gone up by as much as 45% on the back of a key development.
This morning the company announced the payout date and the record date in relation to the dividends. ProTek revealed this morning that it is looking to launch the most ambitious business developments. On the other hand, the company also announced that it is going to payout the dividends on August 30, 2021 for investors of record as of July 30, 2021. News about a dividend payout is almost always a positive one for companies since it attracts investors and that seems to have been the case with the ProTek stock this morning as well.
There is another important development that investors ought to be aware of when they look into the ProTek Capital stock. Not too long ago the company completed the acquisition of Black Dragon Resource Companies Inc and it could prove to be a key part of its operations going forward.
Black Dragon had been acquired by ProTek so that it could become in incubator in which digital assets, blockchain programming and non-fungible tokens or NFTs could be developed. It was an ambitious move from the company and one that could have a long term effect on ProTek. Investors could consider keeping the ProTek stock in their watch lists this week.
NanoVibronix Inc (NASDAQ:NAOV) Is About To Hit $3: A Good Buy Now?
If you are currently hunting for a big mover in the market then it might be time to take a closer look at the NanoVibronix Inc (NASDAQ:NAOV) stock. It has managed to emerge as one of the biggest gainers over the past week or so and has gone up by as much as 35% this morning.
The latest rally has taken the gains made by the NanoVibronix stock over the past week to as much as 200%. The company is involved in the medical device industry and best known for producing PainShield and UroShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices. The stock is on the move because recently the company announced that it successfully completed the first order that had been placed for its new age pain management device PainShield Plus.
It was a major development for the company and the reaction in the markets to that update was perfectly understandable. In this regard, there is another thing that needs to be factored in by investors. NanoVibronix also revealed that the revenues generated from the first sale of PainShield Plus units are going to be recognised in the third quarter of 2021.
In addition to that, the product is certainly an upgrade on the previous PainShield device. It covers twice the surface area as compared to the earlier version of the product. On the other hand, NanoVibronix can also realize higher margins when selling this product and that is possibly another reason behind the optimism among investors.
Dark Pulse Inc (DPLS) Stock Has Lost 60% From Recent High: A Good Buy Now?
Microcap stocks might be quite volatile but at the same time, investors need to keep in mind that these stocks can also deliver enormous gains within a short period of time. Hence, these stocks often attract plenty of followers.
One of the micro-cap stocks to have gained in popularity in recent weeks is that of Dark Pulse Inc (OTCMKTS:DPLS). Last month the stock had made a big jump but at this point, it is down by as much as 60% from its latest highs. In this sort of situation, it is important for investors to perhaps figure out if the fall in the stock could be an opportunity to get into it.
One of the most important things to point out with regards to the Dark Pulse stock is that it continues to be hugely popular from among micro-cap stocks and that had initially been the reason behind its remarkable rally. More importantly, some of the biggest players in penny stocks have taken note of the stock and that was another factor behind the strong rally.
On the other hand, the Dark Pulse stock is one of the most searched stocks among micro-cap stocks at this point in time and there is a fair degree of online buzz around it. Online chatter around a stock is a major factor that is hard to ignore. Hence, despite the fall from its high the Dark Pulse stock could be one to keep an eye on over the coming days.
Infinity Pharmaceuticals (NASDAQ:INFI) Stock Bounces Back After Yesterday’s Fall
On Tuesday, the Infinity Pharmaceuticals (NASDAQ:INFI) stock had suffered from a heavy selloff and had gone down by as much as 61%. However, this morning it is a different stock for the company as the stock has recovered strongly and gone up by as much as 38%.
There has been no fresh news about the company this morning and hence, the rally in the stock could be related to the announcement made by the company yesterday. On Tuesday, Infinity provided updates with regards to the MARIO-275 randomized placebo-based Phase 2 study into its flagship product eganelisib. In this study, the product, which is meant for reversing the immune suppression in cancer patients and spark anti-tumor activity, was administered to the patients in combination with nivolumab.
As per the data from the company that was released on Tuesday, the median overall survival figure when administered with this combination shot up to as much as 15.9 months. In comparison, patients who had only been administered with nivolumab had a median survival rate of 7.9 months. Hence, it is clear to see why the latest data released by Infinity Pharmaceuticals may have come as a source of considerable excitement for many investors.
The data suggests that if eganelisib is added to the standard medication for cancer patients, then there is a high chance of progression-free survival for patients. Hence, it is now going to be interesting to see if the stock can continue to add to its gains today in light of the positive data.
Hive Blockchain Technologies (HVBT) (HIVE) Stock Makes a Strong Comeback: Here is Why
In recent times, it has been a pretty tough time for companies that are involved in the blockchain and crypto industries. Many of the stocks have been volatile as well, however, Hive Blockchain Technologies Ltd (CVE: HIVE) (NASDAQ:HVBT) seemed to be on the path to recovery yesterday and surged by as much as 17% and took its gains for the past week to 28%.
The surge in the HIVE Blockchain stock is directly related to the rise in the price of cryptocurrencies in recent days. Hence, it might be the right time for investors to look a bit more closely into the company and its business. The company, which is regarded as the first company to have opted for using green energy for cryptocurrency mining, had gone public back in 2017. As of July 12, 2021, the company owned as many as 605 Bitcoins.
Since the company is involved in the mining business, the reward it earns is directly related to the price of the cryptocurrencies that it mines. The higher the price of cryptocurrencies, the better it is for mining companies like HIVE Blockchain. In this regard, it should be noted that earlier on in the month HIVE Blockchain also became a member of the NVIDIA Partner Network Cloud Service Provider program. In addition to that, the company also signed purchase agreements for GPUs from NVIDIA for a total value in excess of $66 million. The company’s move is an indication that it is looking to pivot into a new industry altogether in the future.
Is Healthier Choices Management (HCMC) Stock a Good Buy After The Big Fall?
Over the course of the past months, there had been a certain degree of excitement about the patent infringement lawsuit that had been filed by Healthier Choices Management Corp (OTCMKTS:HCMC) against tobacco giant Phillip Morris USA Inc.
However, the Healthier Choices suffered a major setback yesterday after the motion to dismiss the lawsuit by Phillip Morris USA and Phillip Morris Products SA was granted by the District Court for the Northern District of Georgia. The possibility of a large settlement had caused a lot of buzz around the Healthier Choices stock and driven a certain degree of speculation as well. The decision from the court yesterday came as a significant blow to the company’s stock and it tanked by as much as 17%.
It is now going to be interesting to see if the stock can make a quick recovery or not. In this regard, it might be a good idea for investors to keep in mind that all is not lost for Healthier Choices. The court has actually given the company a period of 14 days within which it can submit an amended complaint against Phillip Morris USA.
The company notified that it is going to take up the option and submit such a complaint before the deadline. Last week the company had been in the news after it announced that it was awarded a United States patent for the Electronic Vaporizer Cartridge with Encased Heat Source. The encasing of the cartridge with non-reactive materials is meant for promoting safe vaping.
Why HUMBL Inc (HMBL) Stock Keep On Falling Since February?
At the turn of the year, HUMBL Inc (OTCMKTS:HMBL) was one of the most popular penny stocks in the market and recorded enormous gains on the back of heavy interest from investors.
However, the stock has given up as much as 22% of its gains over the course of the past month and has now gone below the psychologically important level of $1 a share. In this situation, it is perhaps important for investors to figure out if it might be an opportunity to get into the HUMBL stock. Earlier in the month, it was announced that the Chief Executive Officer of the company Brian Foote decided to retire as many as 9350 Series B preferred shares in HUMBL that he owned.
It was a significant move considering the fact that those shares are equal to as many as 93,500,000 shares of the HUMBL common stock. A reduction in the number of shares can sometimes lead to a spike in the share price and hence, it is a development that might have a long-term effect on the HUMBL stock one way or another.
The total value of the shares when the request was sent in by Foote stood at $100,000,000. In this context, it is also necessary for investors to keep in mind that it was not the first time that Foote decided to go for such a move. Back in November last year, he had retired as many as 551,669,335 pre-split shares of the HUMBL common stock from the float.
Relief Therapeutics Holding AG (RLFTF) Stock Makes an Interesting Move: Are You Excited?
This morning many investors are going to be looking into stocks that recorded considerable gains last week and by that token, it is likely that the Relief Therapeutics Holding AG (OTCMKTS:RLFTF) stock is going to be one of those. The stock recorded gains of 25.50% this past Friday and ended the week with cumulative gains of as much as 57%.
Hence, it might be a good idea to actually keep an eye on the Relief stock this morning. The rally in the stock was brought about by a press release from the company’s collaboration partner NRx Pharmaceuticals last week. In the press release, the company provided information about a key milestone regarding aviptadil, the product on which the two companies are working.
NRx revealed that a commercial formulation of aviptadil that could be put to intravenous use had been validated. That is a major development since the company will now start preparing for industrial-scale manufacturing of the product. It was also noted that the aviptadil that is going to be commercially manufactured will also have the stability of a year or more as long as it is stored in ideal conditions.
On the other hand, NRx has also managed to boost its manufacturing capacity and is in a position to boost the manufacturing lot size of aviptadil by 30 to 50 times. It was a major development and it was no surprise that the Relief Therapeutics stock moved in such a big way. It remains to be seen if the stock can continue to add to its gains today.